The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

An international trial identified three new, all-oral drug regimens for drug-resistant tuberculosis, improving treatment ...

A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

Tuberculosis spreads through germs released when a person with TB in their lungs coughs, speaks or sings. These bacteria can ...

As one of the largest tuberculosis outbreaks in the U.S. unfolds in Kansas, UC San Diego researchers and their colleagues ...

Every year, thousands of people in North Carolina get sick with the flu. However, a new illness is on the rise.

Multidrug-resistance is a significant challenge in eliminating the bacterial disease, as the complication increases treatment ...

Studies show under-representation of children and teens with multidrug-resistant TB, calling for focused case-finding efforts ...